Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A prospective, cumulative study of testosterone-undecanoate in hypogonadal men : An Observational registry record study

Next Previous
Trial Profile

A prospective, cumulative study of testosterone-undecanoate in hypogonadal men : An Observational registry record study

Status: Recruiting
Phase of Trial: Phase IV

Latest Information Update: 03 Nov 2020

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Testosterone undecanoate (Primary)
  • Indications Hypogonadism
  • Focus Adverse reactions; Therapeutic Use

    • Most Recent Events

    • 25 Sep 2020 Results assessing effects of long-term therapy with testosterone on liver metabolism and MACE over 11 years in men with hypogonadism and type 2 diabetes, presented at the 56th Annual Meeting of the European Association for the Study of Diabetes
    • 18 Mar 2019 Results assessing the effect of Testosterone Undecanoate Injections in men with Hypogonadism and Osteoporosis (n=102), presented at the 101st Annual Meeting of the Endocrine Society
    • 05 Oct 2018 Results assessing long-term testosterone therapy in hypogonadal men with T2DM (n=311) presented at the 54th Annual Meeting of the European Association for the Study of Diabetes
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top